Endocrinology · 2005 · 124 citations · 46 references
MedicineEndocrinologyNutritional SciencesBone MetabolismCell SignalingSignal TransductionBone Density RegulationBone EndocrinologyBone FormationBone ResorptionBone TurnoverOsteoclast BiologyBone Mineral Density DeclineBone Resorption InhibitionDisuse-induced Bone LossLeptin SignalingOsteoclast RegulationOsteoprotegerin SignalingRankl Opg SignalingRankl Signaling
In vitro studies have demonstrated leptin-positive effects on the osteoblast lineage and negative effects on osteoclastogenesis. Therefore, we tested the hypothesis that leptin may prevent tail-suspension-induced bone loss characterized by an uncoupling pattern of bone remodeling, through both mechanisms. Female rats were randomly tail-suspended or not and treated either with ip administration of leptin or vehicle for 3, 7, and 14 d. As measured by dual energy x-ray absorptiometry, tail-suspension induced a progressive decrease in tibia-metaphysis bone mineral density, which was prevented by leptin. Histomorphometry showed that this was related to the prevention of the transient increase in osteoclast number observed with suspension at d 7. These effects could be mediated by the receptor activator of nuclear factor kappaB-ligand (RANKL)/osteoprotegerin (OPG) pathway since we observed using direct RT-PCR, a suspension-induced increase in RANKL gene expression in proximal tibia at d 3, which was counterbalanced by leptin administration with a similar 3-fold increase in OPG expression and a RANKL to OPG ratio close to nonsuspended conditions. In addition, leptin prevented the decrease in bone formation rate induced by tail-suspension at d 14. The latter could be related to the role of leptin in mediating the reciprocal differentiation between adipocytes and osteoblasts, because leptin concurrently blunted the disuse-induced increase in bone marrow adipogenesis. In summary, these data suggest that peripheral administration of leptin could prevent disuse-induced bone loss through, first, a major inhibitory effect on bone resorption and, second, a delayed effect preventing the decrease in bone formation.
46
Leptin Inhibits Bone Formation through a Hypothalamic Relay
Patricia Ducy, Michael Amling, Shu Takeda et al. · Cell · 2000 · 2.1K citations · Full text
Medicine, Endocrinology, Physiology +13
Leptin Regulates Bone Formation via the Sympathetic Nervous System
Shu Takeda, Florent Elefteriou, Régis Levasseur et al. · Cell · 2002 · 1.7K citations · Full text
Medicine, Endocrinology, Physiology +14
Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ
Erding Hu, Jae Bum Kim, Pasha Sarraf et al. · Science · 1996 · 1K citations
Recombinant Human Leptin in Women with Hypothalamic Amenorrhea
Corrine K. Welt, Jean L. Chan, John W. Bullen et al. · New England Journal of Medicine · 2004 · 916 citations
Medicine, Endocrinology, Physiology +16